Seastar Medical Reaches Interim Enrollment Target For NEUTRALIZE-AKI Pivotal Trial Of SCD Therapy For Adult Patients With Acute Kidney Injury

  • Kevin Chung

Press/Media

Period13 May 2025

Media coverage

1

Media coverage

  • TitleSeastar Medical Reaches Interim Enrollment Target For NEUTRALIZE-AKI Pivotal Trial Of SCD Therapy For Adult Patients With Acute Kidney Injury
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date13/05/25
    PersonsKevin Chung